André Gerth
Keine laufenden Positionen mehr
Profil
André Gerth served as the Chief Executive Officer & IR Contact at Vita 34 AG from 2012 to 2017.
Prior to that, he was the Managing Director at BioPlanta GmbH from 1992 to 2012.
He also served as the Managing Director at stellacure GmbH.
Dr. Gerth holds a doctorate degree from Universität Leipzig.
Ehemalige bekannte Positionen von André Gerth
| Unternehmen | Position | Ende |
|---|---|---|
| VITA 34 AG | Vorstandsvorsitzender | 12.06.2017 |
BioPlanta GmbH
 BioPlanta GmbH Pharmaceuticals: OtherHealth Technology Part of Active Ownership Capital SARL, BioPlanta GmbH is a German company that researches, develops, and distributes botanical active agents for pharmaceutical purposes. The company is based in Leipzig, Germany. BioPlanta was acquired by Vita 34 AG on May 16, 2012 for $1.47 million. | Vorstandsvorsitzender | 01.07.2012 |
stellacure GmbH
 stellacure GmbH Medical/Nursing ServicesHealth Services stellacure GmbH provides cord blood and stem cell banking services. It specializes in the removal, processing, and deposit of stem cells from the umbilical cord blood. The firm also engages in partnerships with life sciences advisory firms and blood service units. The company was founded in 2006 and is headquartered in Leipzig, Germany. | Vorstandsvorsitzender | - |
Ausbildung von André Gerth
| Universität Leipzig | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VITA 34 AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
BioPlanta GmbH
BioPlanta GmbH Pharmaceuticals: OtherHealth Technology Part of Active Ownership Capital SARL, BioPlanta GmbH is a German company that researches, develops, and distributes botanical active agents for pharmaceutical purposes. The company is based in Leipzig, Germany. BioPlanta was acquired by Vita 34 AG on May 16, 2012 for $1.47 million. | Health Technology |
stellacure GmbH
stellacure GmbH Medical/Nursing ServicesHealth Services stellacure GmbH provides cord blood and stem cell banking services. It specializes in the removal, processing, and deposit of stem cells from the umbilical cord blood. The firm also engages in partnerships with life sciences advisory firms and blood service units. The company was founded in 2006 and is headquartered in Leipzig, Germany. | Health Services |
